VINPAI Share Price

ALVIN

FR001400AXT1

Personal Products

Market Closed - Euronext Paris 16:55:00 28/10/2026 GMT			5-day change	1st Jan Change
2.660 ^EUR	0.00%		+9.92%	-25.70%

10-01	Vinpai SAS Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-16	Vinpai Reports Unaudited Revenue Results for the Second Quarter and First Half of Fiscal Year Ended June 30, 2026	CI

Analysts' recommendations: VINPAI

06-19	The simplified tender offer for Vinpai shares opens Tuesday
27/01/25	Invest Securities Downgrades Vinpai to Neutral, Cuts PT	MT
05/11/24	Vinpai: Invest Securities lowers its target price
03/10/24	Vinpai: Invest Securities reduces its target price on the stock
26/09/23	Vinpai: on the rise, an analyst initiates a buy on the stock

More recommendations

News in other languages: VINPAI

10-01	Vinpai publie ses résultats financiers semestriels 2026
07-16	Vinpai annonce un chiffre d’affaires de 3,8M€ au 1er semestre de son exercice 2026
07-08	Succès de l’offre publique d’achat simplifiée par CAMLIN FINE SCIENCES visant les actions de Vinpai
07-07	Camlin Fine Sciences dépasse les 90% du capital de Vinpai
06-19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré

More news

Managers and Directors: VINPAI

Manager	Title	Age	Since
Philippe Le Ray CEO	Chief Executive Officer	58	31/08/2011

Director	Title	Age	Since
Cyrille Damany CHM	Chairman	66	31/08/2011
Philippe Le Ray BRD	Director/Board Member	58	31/08/2011
Christian Jouno BRD	Director/Board Member	70	07/06/2022

More insiders

VINPAI specializes in the manufacture and marketing of algae and plant-based functional ingredients for the food, cosmetics and medical industries. The activity is organized around 4 families of products: - functional ingredient solutions for the food industry: plant-based flavors, cheese solutions, dairy alternatives, salt reduction solutions, algal solutions for texturing, plant-based cookies, etc.; - algo-mineral solutions for the cosmetics industry: for the skin care and sun protection markets; - food supplements and nutraceutic actives: made from essential oils and marine bio-resources of algal origin; - algo-sourced solutions for medical devices: Cutaneous patches enriched in brown algae extracts and essential oils, molding powders designed to produce soft molds or imprints, aesthetic and dental hygiene products, etc.

Employees

Sector

Personal Products

Calendar

10-30 Sales and Revenue Release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
28/10/26	€2.660	0.00%	0
27/10/26	€2.660	0.00%	0
26/10/26	€2.660	0.00%	0
23/10/26	€2.660	0.00%	0
22/10/26	€2.660	+9.92%	65

Real-time Euronext Paris

More quotes

Stock Market
Stocks
ALVIN Stock

As early as today, start finding the best investment opportunities!

Market Cap	12.06M 13.44M 11.15M 10.1M 18.87M 1.28B 19.1M 133M 53.11M 670M 50.45M 49.39M 2.13B	P/E 2024	-3.5x	P/E 2025	-3.34x
Enterprise Value	16.25M 18.12M 15.03M 13.61M 25.43M 1.73B 25.73M 180M 71.56M 903M 67.98M 66.55M 2.87B	EV / Sales 2024	1.86x	EV / Sales 2025	1.61x
Free-Float	4.17%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALVIN	Real-time
Deutsche Boerse AG	J7Y	Delayed
Börse Stuttgart	J7Y	Delayed

10-01	Vinpai SAS Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-16	Vinpai Reports Unaudited Revenue Results for the Second Quarter and First Half of Fiscal Year Ended June 30, 2026	CI
07-09	Camlin Fine Sciences Ownership in Vinpai Tops 95% After Cash Tender Offer	MT
07-05	Camlin Fine Sciences Limited completed the acquisition o 11.00049 % stake in Vinpai SAS for ?1.8 million.	CI
06-19	The simplified tender offer for Vinpai shares opens Tuesday
06-19	French Financial Regulator Clears India's Camlin Fine Sciences' Offer for Remaining Vinpai Shares	MT
05-03	Camlin Fine Sciences Limited proposed to acquire remaining 15.60% stake in Vinpai SAS for ?2.6 million.	CI
05-03	Vinpai SAS Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-15	Hermès, Stellantis, Vinpai...stocks to watch today in Paris -
04-15	Vinpai: Losses widen in 2025 despite revenue growth
04-13	Weekly Earnings Calendar: JPMorgan and Netflix in the US, LVMH and ASML in Europe,
01-29	Vinpai Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
12-24	Sanofi, Synergie, Savencia... Stocks to Watch Today in Paris

10-01	Vinpai Releases Its 2026 Half-Year Financial Results	BU
07-16	Vinpai Reports Revenue of €3.8 Million for the First Half of Its 2026 Fiscal Year	BU
07-08	Succes of the Simplified Tender Offer by CAMLIN FINE SCIENCES on Vinpai Shares	BU
06-18	French Stock Market Authority Clearance Decision Regarding the Mandatory Tender Offer by CAMLIN FINE SCIENCES on Vinpai Shares	BU
05-04	Filing on May 4, 2026 of the Draft of the Mandatory Tender Offer by CAMLIN FINE SCIENCES on Vinpai Shares	BU

1 week	+9.92%
Current month	+6.40%
1 month	+10.83%
3 months	-8.28%
6 months	-24.86%
Current year	-25.70%

VINPAI Share Price

Stocks

ALVIN

FR001400AXT1

Personal Products

Valuation: VINPAI

Chart: VINPAI

Latest news: VINPAI

Analysts' recommendations: VINPAI

Press Releases: VINPAI

News in other languages: VINPAI

Quotes and Performance

Price Extremes

Managers and Directors: VINPAI

Cosmetics & Perfumes

Financials

Company Profile

Quotes

1 week	2.66	2.66
1 month	2.36	2.72
Current year	2.18	3.62
1 year	2.18	3.62
3 years	2.18	5.75
5 years	2.18	7.7
10 years	2.18	7.7

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VINPAI	0.00%	+9.92%	-24.00%	-46.81%	13.44M
PROCTER & GAMBLE COMPANY	-0.53%	+1.05%	+4.70%	+6.18%	369B
L'ORÉAL	-1.50%	+4.42%	+14.36%	+8.06%	255B
UNILEVER PLC	-2.05%	-0.58%	-8.02%	+10.28%	140B
COLGATE-PALMOLIVE COMPANY	-0.52%	-1.82%	+18.87%	+24.12%	73.48B
GALDERMA GROUP AG	+0.11%	+6.28%	+29.60%	-	52.06B
HINDUSTAN UNILEVER LIMITED	-0.12%	-2.02%	-27.71%	-26.84%	44.97B
ESTEE LAUDER	+0.89%	+5.47%	+10.70%	-14.57%	39.2B
KENVUE INC.	-0.51%	+1.52%	+33.22%	+3.70%	37.32B
KIMBERLY-CLARK CORPORATION	-0.64%	+1.65%	-10.16%	-9.31%	36.28B
Average	-0.43%	+1.03%	+4.16%	-5.02%	104.77B
Weighted average by Cap.	-0.80%	+1.68%	+6.91%	+5.60%

	2024	2025
Net sales	9.16M 10.21M 8.47M 7.67M 14.32M 972M 14.5M 101M 40.32M 509M 38.3M 37.49M 1.61B	10.21M 11.38M 9.44M 8.55M 15.97M 1.08B 16.17M 113M 44.96M 567M 42.71M 41.8M 1.8B
Net income	-2.92M -3.25M -2.7M -2.44M -4.57M -310M -4.62M -32.26M -12.85M -162M -12.21M -11.95M -515M	-4.86M -5.42M -4.49M -4.07M -7.6M -516M -7.69M -53.71M -21.39M -270M -20.32M -19.89M -857M
Net Debt	6.68M 7.45M 6.18M 5.6M 10.45M 709M 10.58M 73.87M 29.42M 371M 27.95M 27.36M 1.18B	4.19M 4.67M 3.87M 3.51M 6.56M 445M 6.64M 46.33M 18.45M 233M 17.53M 17.16M 739M